The HIV care continuum in Latin America: Challenges and opportunities

The Lancet Infectious Diseases

Volumn 15, Issue 7, 2015, Pages 833-839

  Piñeirúa, Alicia ^a,b   Sierra Madero, Juan ^b   Cahn, Pedro ^c   Guevara Palmero, Rafael Napoleón ^d   Martínez Buitrago, Ernesto ^e   Young, Benjamin ^f,g   Del Rio, Carlos ^a,h  

^a EMORY UNIVERSITY   (United States)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c FUNDACIÓN HUÉSPED   (Argentina)

^d HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

^e UNIVERSIDAD DEL VALLE   (Colombia)

^f INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE   (United States)

^g UNIVERSITY OF DENVER   (United States)

^h EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

DISEASE TRANSMISSION; EARLY INTERVENTION; HEALTH CARE; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SOUTH AND CENTRAL AMERICA; TREATMENT PLANNING; CD4 LYMPHOCYTE COUNT; EARLY DIAGNOSIS; HIV INFECTIONS; IMMUNOLOGY; PATIENT CARE; PREVALENCE; VIRUS LOAD;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CONTINUITY OF PATIENT CARE; EARLY DIAGNOSIS; HIV INFECTIONS; HUMANS; LATIN AMERICA; PREVALENCE; VIRAL LOAD;

EID: 84937412709     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(15)00108-5     Document Type: Review

References (54)

1. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998, 338:853-860.
2. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011, 365:493-505.
3. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 2011, 52:793-800.
4. Monitoring HIV care in the United States: a strategy for generating national estimates of HIV care and coverage 2012, Institute of Medicine (IOM), The National Academies Press, Washington, DC.
5. Global Report: UNAIDS report on the global AIDS epidemic 2013 2013, Joint UN Programme in HIV/AIDS, UNAIDS, Geneva, Switzerland.
6. Kerr LR, Mota RS, Kendall C, et al. HIV among MSM in a large middle-income country. AIDS 2013, 27:427-435.
7. van Griensven F, de Lind van Wijngaarden JW, Baral S, Grulich A The global epidemic of HIV infection among men who have sex with men. Curr Opin HIV AIDS 2009, 4:300-307.
8. Cáceres CF, Stall R Commentary: The human immunodeficiency virus/AIDS epidemic among men who have sex with men in Latin America and the Caribbean: it is time to bridge the gap. Int J Epidemiol 2003, 32:740-743.
9. Bastos FI, Cáceres C, Galvão J, Veras MA, Castilho EA AIDS in Latin America: assessing the current status of the epidemic and the ongoing response. Int J Epidemiol 2008, 37:729-737.
10. Rossi D, Pawlowicz MP, Rangugni V, et al. The HIV/AIDS epidemic and changes in injecting drug use in Buenos Aires, Argentina. Cad Saude Publica 2006, 22:741-750.
11. Figueroa JP The HIV epidemic in the Caribbean: meeting the challenges of achieving universal access to prevention, treatment and care. West Indian Med J 2008, 57:195-203.
12. Teva I, Bermúdez MP, Ramiro MT, Buela-Casal G Current epidemiological situation of HIV/AIDS in Latin America: analysis of differences among countries. Rev Med Chil 2012, 140:50-58.
13. Antiretroviral treatment in the spotlight: a public health analysis in Latin America and the Caribbean 2013 2013, Pan American Health Organization, Pan American Health Organization, Washington, DC.
14. Arán-Matero D, Amico P, Arán-Fernandez C, Gobet B, Izazola-Licea JA, Avila-Figueroa C Levels of spending and resource allocation to HIV programs and services in Latin America and the Caribbean. PLoS One 2011, 6:e22373.
15. Boletín No. 25, SALVAR. Sistema de administración, logística y vigilancia de ARV: datos al 30 de Junio de 2014 2014, Centro Nacional Para la Prevención y el Control del VIH/SIDA (CENSIDA), CENSIDA, Miguel Hidalgo, DF.
16. Guía clínica: síndrome de la inmunodeficiencia adquirida VIH/SIDA 2010. Serie Guías Clínicas MINSAL 2010, Minsitry of Health, Government of ChileGovernment of Chile, Ministry of Health, Santiago, Chile.
17. Guía de manejo antiretroviral de las personas con VIH 2012, Centro Nacional Para la Prevención y el Control del VIH/SIDA, Ministry of Health, México City.
18. Resumen de la guía para el manejo del tratamiento antiretroviral de las personas que viven con VIH/SIDA en Venezuela 2014, Ministerio del Poder Popular para la Salud, Bolivarian Government of Venezuela, Caracas, Venezuela.
19. Guía para el manejo de VIH/SIDA basada en la evidencia Colombia 2012, Modelo de Gestión Programática en VH SIDA, Ministry of Health, Bogotá, Colombia.
20. Guía para el manejo de los pacientes adultos con infección por VIH 2013, Dirección de SIDA y ETS, Ministry of Health, Buenos Aires, Argentina.
21. Bautista-Arredondo S, Colchero MA, Romero M, Conde-Glez CJ, Sosa-Rubí SG Is the HIV epidemic stable among MSM in Mexico? HIV prevalence and risk behavior results from a nationally representative survey among men who have sex with men. PLoS One 2013, 8:e72616.
22. Crabtree-Ramírez B, Caro-Vega Y, Belaunzarán-Zamudio F, Sierra-Madero J High prevalence of late diagnosis of HIV in Mexico during the HAART era. Salud Publica Mex 2012, 54:506-514.
23. Bonjour MA, Montagne M, Zambrano M, et al. Determinants of late disease-stage presentation at diagnosis of HIV infection in Venezuela: a case-case comparison. AIDS Res Ther 2008, 5:6.
24. Crabtree-Ramírez B, Caro-Vega Y, Shepherd BE, et al. Cross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters. PLoS One 2011, 6:e20272.
25. Ettenger A, Bärnighausen T, Castro A Health insurance for the poor decreases access to HIV testing in antenatal care: evidence of an unintended effect of health insurance reform in Colombia. Health Policy Plan 2014, 29:352-358.
26. Colasanti J, Lorio Rugama M, Lifschitz K, et al. HIV testing rates among pregnant women in Managua, Nicaragua, 2010-2011. Rev Panam Salud Publica 2013, 33:15-21.
27. La cobertura de pruebas de detección del VIH en embarazadas en México. Boletín del grupo de Información Sectorial en VIH/SIDA 2011, Centro Nacional para la prevención y el control del VIH/SIDA, Comité de Monitoreo y Evaluación, México City.
28. Arrivillaga M, Hoyos PA, Tovar LM, Varela MT, Correa D, Zapata H HIV testing and counselling in Colombia: evidence from a national health survey and recommendations for health-care services. Int J STD AIDS 2012, 23:815-821.
29. Galindo-Quintero J, Mueses-Marin HF, Montaño-Agudelo D, et al. HIV testing and counselling in Colombia: local experience on two different recruitment strategies to better reach low socioeconomic status communities. Aids Res Treat 2014, 2014:803685.
30. Nogueda Orozco MJ, Caro-Vega Y, Díaz-Sosa D, Crabtree-Ramírez B, Sierra-Madero J. HIV-related self-stigma as a risk factor for late HAART initiation in Mexico. 19th International AIDS Society conference; Washington, DC; July 22-25, 2012. Abstract number THPE451.
31. Socías ME, Hermida L, Singman M, et al. Routine HIV testing among hospitalized patients in Argentina. Is it time for a policy change?. PLoS One 2013, 8:e69517.
32. Espinoza H, Sequeira M, Domingo G, Amador JJ, Quintanilla M, de los Santos T Management of the HIV epidemic in Nicaragua: the need to improve information systems and access to affordable diagnostics. Bull World Health Organ 2011, 89:619-620.
33. Resolución 2338. Colombia: Diario Oficial No. 48.840 Columbian Ministry of Health and Social Protection, (accessed May 20, 2015). http://normativa.colpensiones.gov.co/colpens/docs/pdf/resolucion_minsaludps_2338_2013.pdf.
34. Metsch LR, Pereyra M, Messinger S, et al. HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care. Clin Infect Dis 2008, 47:577-584.
35. Broughton E, Nunez D, Moreno I Cost-effectiveness of improving health care to people with HIV in Nicaragua. Nurs Res Pract 2014, 2014:232046.
36. Bofill LM, Lopez M, Dorigo A, et al. Patient-provider perceptions on engagement in HIV care in Argentina. AIDS Care 2014, 26:602-607.
37. Caceres CF, Konda K, Silva-Santisteban A, et al. The continuum of HIV care in Peru-where are we now? Key lessons from an estimation in the context of very limited data. AIDS Res Hum Retroviruses 2014, 30(suppl):A109. Abstract P08.02.
38. Situación del VIH/SIDA en Colombia, 2013 2014, Fondo Colombiano de Enfermedades de Alto Costo, Cuenta de Alto Costo, Colombia.
39. Holtgrave DR, Hall HI, Prejean J HIV transmission rates in the United States, 2006-2008. Open AIDS J 2012, 6:26-28.
40. Nosyk B, Montaner JS, Colley G, et al. The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study. Lancet Infect Dis 2014, 14:40-49.
41. Hull MW, Wu Z, Montaner JS Optimizing the engagement of care cascade: a critical step to maximize the impact of HIV treatment as prevention. Curr Opin HIV AIDS 2012, 7:579-586.
42. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach 2013, WHO, World Health Organization, Geneva.
43. Larson BA, Brennan A, McNamara L, et al. Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Trop Med Int Health 2010, 15(suppl 1):43-47.
44. Larson BA, Brennan A, McNamara L, et al. Lost opportunities to complete CD4+ lymphocyte testing among patients who tested positive for HIV in South Africa. Bull World Health Organ 2010, 88:675-680.
45. Amuron B, Namara G, Birungi J, et al. Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health 2009, 9:290.
46. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents US Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, (accessed April 5, 2014). http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
47. Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA 2012, 308:387-402.
48. Thompson MA, Mugavero MJ, Amico KR, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med 2012, 156:817-833.
49. Osorio-de-Castro CG, Crisante M, Miranda ES, Oliveira EA, Oliveira MA Proposed methodology for monitoring antiretroviral drugs price negotiations in Latin America and the Caribbean. Rev Panam Salud Publica 2009, 26:137-147.
50. Althoff KN, Gebo KA, Gange SJ, et al. CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?. AIDS Res Ther 2010, 7:45.
51. Craw JA, Gardner LI, Marks G, et al. Brief strengths-based case management promotes entry into HIV medical care: results of the antiretroviral treatment access study-II. J Acquir Immune Defic Syndr 2008, 47:597-606.
52. Ulett KB, Willig JH, Lin HY, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS 2009, 23:41-49.
53. Vermund SH, Hayes RJ Combination prevention: new hope for stopping the epidemic. Curr HIV/AIDS Rep 2013, 10:169-186.
54. Gardner EM, Young B The HIV care cascade through time. Lancet Infect Dis 2014, 14:5-6.